Skip to content

Nasdaq · CIK 0000318306

ABEO ABEONA THERAPEUTICS INC.

Insider trading from SEC Form 4. Last filing 13 d ago. Close $4.94 on Oct 9, 2026, +18% from the 52-week low and -34% from the high.

Last 90 days

Net insider value
-$296k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
5
$296k by 5 insiders
Insiders on file
12
with a Form 4 at this company

Price and insider trades, last year

ABEOOct 9, 2026 · close 4.94

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at ABEONA THERAPEUTICS INC., scored.

ScoreInsiderValueHoldingsPrice contextFiled
35WeakMadhav Vasanthavada
Chief Commercial Officer
sell
$25k
4,902 shares
-2%-
36WeakBrendan M. O'Malley
SVP, Chief Legal Officer
sell
$35k
6,727 shares
-2%-
43ModerateJoseph Walter Vazzano
Chief Financial Officer
sell
$47k
9,191 shares
-2%-
50ModerateVishwas Seshadri
Chief Executive Officer
sell
$101k
19,608 shares
-2%-
29WeakMark Alvino
director
sell
$88k
15,000 shares
-19%-
38WeakBrendan M. O'Malley
SVP, General Counsel
sell
$71k
10,470 shares
-3%+61% from low-2% from high
55ModerateVishwas Seshadri
Chief Executive Officer
sell
$343k
50,676 shares
-4%+61% from low-2% from high
47ModerateJoseph Walter Vazzano
Chief Financial Officer
sell
$120k
17,795 shares
-3%+61% from low-2% from high
30WeakMark Alvino
director
sell
$13k
2,000 shares
-2%+46% from low-11% from high
21WeakMark Alvino
director
sell
$45k
8,000 shares
-8%+46% from low-11% from high
15WeakVishwas Seshadri
Chief Executive Officer
sell
$120k
25,000 shares
-2%-
15WeakMark Alvino
director
sell
$22k
4,000 shares
-6%-
15WeakMark Alvino
director
sell
$20k
4,000 shares
-6%-

Transactions

The last 29 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 29, 2026Brendan M. O'Malley
SVP, Chief Legal Officer
SOpen-market sale
Common Stock
-6,727$5.16$35k421,22613 d ago
Sep 29, 2026Joseph Walter Vazzano
Chief Financial Officer
SOpen-market sale
Common Stock
-9,191$5.16$47k482,88813 d ago
Sep 29, 2026Vishwas Seshadri
Chief Executive Officer
SOpen-market sale
Common Stock
-19,608$5.16$101k1,286,50013 d ago
Sep 29, 2026Madhav Vasanthavada
Chief Commercial Officer
SOpen-market sale
Common Stock
-4,902$5.16$25k285,72113 d ago
Sep 1, 2026Mark Alvino
director
SOpen-market sale
Common Stock
-15,000$5.86$88k62,06541 d ago
Jun 5, 2025Joseph Walter Vazzano
Chief Financial Officer
AGrant or award
Common Stock
+13,333$0.00$0504,579Jun 9, 2025
Jun 6, 2025Brendan M. O'Malley
SVP, General Counsel
SOpen-market sale
Common Stock
-10,470$6.76$71k378,245Jun 6, 2025
Jun 6, 2025Vishwas Seshadri
Chief Executive Officer
SOpen-market sale
Common Stock
-50,676$6.76$343k1,303,761Jun 6, 2025
Jun 6, 2025Joseph Walter Vazzano
Chief Financial Officer
SOpen-market sale
Common Stock
-17,795$6.76$120k491,246Jun 6, 2025
Jun 1, 2025Vishwas Seshadri
Chief Executive Officer
FTax withholding
Common Stock
-885$6.24$5,5221,354,437Jun 3, 2025
May 27, 2025Mark Alvino
director
SOpen-market sale
Common Stock
-2,000$6.38$13k90,435May 27, 2025
May 16, 2025Mark Alvino
director
SOpen-market sale
Common Stock
-8,000$5.68$45k92,435May 16, 2025
Mar 31, 2025Vishwas Seshadri
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-25,000$4.78$120k1,355,322Mar 31, 2025
Mar 14, 2025Joseph Walter Vazzano
Chief Financial Officer
FTax withholding
Common stock
-685$5.29$3,624509,041Mar 17, 2025
Mar 3, 2025Brendan M. O'Malley
SVP, General Counsel
FTax withholding
Common Stock
-181$5.24$948388,715Mar 4, 2025
Jan 31, 2025Leila Alland
director
AGrant or award
Common Stock
+36,101$0.00$0154,366Feb 3, 2025
Jan 31, 2025Mark Alvino
director
AGrant or award
Common Stock
+36,101$0.00$0100,435Feb 3, 2025
Jan 31, 2025Michael Amoroso
director
AGrant or award
Common Stock
+36,101$0.00$0180,466Feb 3, 2025
Jan 31, 2025Faith L. Charles
director
AGrant or award
Common Stock
+36,101$0.00$0149,832Feb 3, 2025
Jan 31, 2025Christine Berni Silverstein
director
AGrant or award
Common Stock
+36,101$0.00$0133,572Feb 3, 2025
Jan 31, 2025Eric Crombez
director
AGrant or award
Common Stock
+36,101$0.00$047,145Feb 3, 2025
Jan 31, 2025Donald A. Wuchterl
director
AGrant or award
Common Stock
+36,101$0.00$0150,612Feb 3, 2025
Jan 31, 2025Bernhardt G Zeiher
director
AGrant or award
Common Stock
+36,101$0.00$047,145Feb 3, 2025
Jan 29, 2025Mark Alvino
director
SOpen-market sale
Common Stock
-4,000$5.38$22k64,334Jan 31, 2025
Jan 21, 2025Vishwas Seshadri
Chief Executive Officer
AGrant or award
Common Stock
+476,435$0.00$01,380,322Jan 23, 2025
Jan 21, 2025Joseph Walter Vazzano
Chief Financial Officer
AGrant or award
Common stock
+144,509$0.00$0509,726Jan 23, 2025
Jan 21, 2025Brendan M. O'Malley
SVP, General Counsel
AGrant or award
Common Stock
+115,607$0.00$0388,896Jan 23, 2025
Jan 21, 2025Mark Alvino
director
SOpen-market sale
Common Stock
-4,000$5.10$20k68,334Jan 21, 2025
Oct 16, 2024Vishwas Seshadri
Chief Executive Officer
FTax withholding
Common Stock
-251$6.54$1,642903,887Oct 17, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

ABEO insider trading: ABEONA THERAPEUTICS INC. | InsiderTell